These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 33847006
21. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells. Shin KJ, Kim YL, Lee S, Kim DK, Ahn C, Chung J, Seong JY, Hwang JI. J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268 [Abstract] [Full Text] [Related]
22. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Kim J, Keys JR, Eckhart AD. Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475 [Abstract] [Full Text] [Related]
23. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease. Yang XY, Zhao EY, Zhuang WX, Sun FX, Han HL, Han HR, Lin ZJ, Pan ZF, Qu MH, Zeng XW, Ding Y. Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757 [Abstract] [Full Text] [Related]
24. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues. Ishii S, Tsujiuchi T, Fukushima N. Biochem Biophys Res Commun; 2017 May 06; 486(3):767-773. PubMed ID: 28342860 [Abstract] [Full Text] [Related]
25. The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer. Sahay D, Leblanc R, Grunewald TG, Ambatipudi S, Ribeiro J, Clézardin P, Peyruchaud O. Oncotarget; 2015 Aug 21; 6(24):20604-20. PubMed ID: 26098771 [Abstract] [Full Text] [Related]
26. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury. Santos-Nogueira E, López-Serrano C, Hernández J, Lago N, Astudillo AM, Balsinde J, Estivill-Torrús G, de Fonseca FR, Chun J, López-Vales R. J Neurosci; 2015 Jul 15; 35(28):10224-35. PubMed ID: 26180199 [Abstract] [Full Text] [Related]
27. Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration. Bock-Pereda A, Cruz-Soca M, Gallardo FS, Córdova-Casanova A, Gutierréz-Rojas C, Faundez-Contreras J, Chun J, Casar JC, Brandan E. Matrix Biol; 2024 Nov 15; 133():103-115. PubMed ID: 39153517 [Abstract] [Full Text] [Related]
28. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain. Kajitani N, Okada-Tsuchioka M, Kano K, Omori W, Boku S, Aoki J, Takebayashi M. Biochem Biophys Res Commun; 2020 Oct 15; 531(2):89-95. PubMed ID: 32718668 [Abstract] [Full Text] [Related]
29. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2. Park J, Jang JH, Oh S, Kim M, Shin C, Jeong M, Heo K, Park JB, Kim SR, Oh YS. Cell Signal; 2018 Apr 15; 44():138-147. PubMed ID: 29329782 [Abstract] [Full Text] [Related]
30. LPA1-mediated PKD2 activation promotes LPA-induced tissue factor expression via the p38α and JNK2 MAPK pathways in smooth muscle cells. Hao F, Liu Q, Zhang F, Du J, Dumire A, Xu X, Cui MZ. J Biol Chem; 2021 Oct 15; 297(4):101152. PubMed ID: 34478715 [Abstract] [Full Text] [Related]
31. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Gennero I, Laurencin-Dalicieux S, Conte-Auriol F, Briand-Mésange F, Laurencin D, Rue J, Beton N, Malet N, Mus M, Tokumura A, Bourin P, Vico L, Brunel G, Oreffo RO, Chun J, Salles JP. Bone; 2011 Sep 15; 49(3):395-403. PubMed ID: 21569876 [Abstract] [Full Text] [Related]
32. Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation. Anliker B, Choi JW, Lin ME, Gardell SE, Rivera RR, Kennedy G, Chun J. Glia; 2013 Dec 15; 61(12):2009-22. PubMed ID: 24115248 [Abstract] [Full Text] [Related]
33. Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis. Fransson J, Gómez-Conde AI, Romero-Imbroda J, Fernández O, Leyva L, de Fonseca FR, Chun J, Louapre C, Van-Evercooren AB, Zujovic V, Estivill-Torrús G, García-Díaz B. Mol Neurobiol; 2021 Feb 15; 58(2):470-482. PubMed ID: 32974731 [Abstract] [Full Text] [Related]
34. Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration. Wu DD, Zhang F, Hao F, Chun J, Xu X, Cui MZ. J Biol Chem; 2014 Feb 28; 289(9):5774-83. PubMed ID: 24371135 [Abstract] [Full Text] [Related]
35. c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis. Walker NM, Mazzoni SM, Vittal R, Fingar DC, Lama VN. J Biol Chem; 2018 Nov 02; 293(44):17229-17239. PubMed ID: 30217824 [Abstract] [Full Text] [Related]
36. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer. Liao Y, Mu G, Zhang L, Zhou W, Zhang J, Yu H. Dig Dis Sci; 2013 Dec 02; 58(12):3524-33. PubMed ID: 24061591 [Abstract] [Full Text] [Related]
37. Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells. Fukushima K, Takahashi K, Yamasaki E, Onishi Y, Fukushima N, Honoki K, Tsujiuchi T. Exp Cell Res; 2017 Mar 01; 352(1):139-145. PubMed ID: 28189636 [Abstract] [Full Text] [Related]
38. Discovery of Novel Gq-Biased LPA1 Negative Allosteric Modulators. Shimizu Y, Nakayama M. SLAS Discov; 2017 Aug 01; 22(7):859-866. PubMed ID: 28346103 [Abstract] [Full Text] [Related]
39. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Chen M, Towers LN, O'Connor KL. Am J Physiol Cell Physiol; 2007 May 01; 292(5):C1927-33. PubMed ID: 17496233 [Abstract] [Full Text] [Related]
40. Activation of the ATX/LPA/LPARs axis induces a fibrotic response in skeletal muscle. Córdova-Casanova A, Cruz-Soca M, Chun J, Casar JC, Brandan E. Matrix Biol; 2022 May 01; 109():121-139. PubMed ID: 35385768 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]